|
Flavonoids | Liver injury | Mechanism of action | Conclusion | References |
|
Quercetin | Cholestatic liver injury in rats | Increase ORAI-1 gene expression | Increased ORAI-1 gene-mediated SOCE leads to improved platelet function in the bile duct ligation model of cholestasis in rats | [46] |
t-BHP induced acute liver damage in mice | Scavenge free radical, increase in GSH, CAT, SOD, and decrease in serum enzyme markers i.e., ALT, AST | Through an increase in antioxidant activity, quercetin neutralizes free radicals and lowers oxidative stress | [47] |
|
Hesperetin | Both ethanol and lipopolysaccharide-induced RAW264.7 cells and alcohol induce mouse liver | Enhance NLRP12 in two in vivo and in-vitro models which lowers inflammatory factors and prevents expression and phosphorylation of P65 proteins | Hesperetin stimulated NLRP12 through NF-κB to lessen inflammation and liver damage | [55] |
|
(HD-16) hesperetin derivative | Carbon tetrachloride-induced liver fibrosis and liver inflammation | α-SMA, Col3α1, TIMP-1, and Col1α1 expression were inhibited in TGF-1-stimulated LX-2 cells, and activating the SIRT3/AMPK pathway also reduced carbon tetrachloride-induced liver inflammation and fibrosis | Hesperetin derivative-16 attenuated carbon tetrachloride-induced liver fibrosis and inflammation | [57] |
|
Apigenin | D- galactosamine/LPS-induced liver injury | Decrease in ALT, and AST, and raised the activity of superoxide dismutase, glutathione reductase, catalase, as well as Nrf-2 and PPARγ protein expression, and decrease in hepatic TNF-α, and NF-κB expression | Apigenin may ameliorate D-GalN/LPS-induced liver injury in mice by increased Nrf-2-mediated antioxidative enzyme and modulate the PPARγ/NF-κB mediated expression | [40] |
Edifenphos- induced toxicity by modulating ROS- mediated mitochondrial dysfunction, oxidative stress, and caspase signal pathway in rat liver and kidney | Apigenin ameliorated the edifenphos-induced oxidative damage via antioxidant activity or by scavenging free radicals | Apigenin reduces oxidative stress-induced damage in the liver | [60] |
|
Epicatechin | Acetaminophen-induced acute hepatic injury of mice | Inhibit TNF-α, IL-6, and IL-1, reduce the pathway of mitochondrial apoptosis, increase Bcl-2 to amplify the antiapoptotic response, and inhibit bax caspase-3 | In mice, epicatechin improves the antiapoptotic effect while decreasing the acute liver injury brought on by APAP | [41] |
Hepatic sinusoidal obstruction syndrome by inhibiting liver inflammatory and oxidative injury | In rats, epicatechin increased Nrf-2 translocation and the production of its downstream antioxidant gene | At a dosage of 0.02–0.04 g/kg, epicatechin reduced hepatic sinusoidal syndrome by reducing hepatic inflammation and oxidative stress | [61] |
|
Malvidin | Lipopolysaccharide-induced acute liver injury | Reduce oxidative damage by activating the Nrf2 signalling cascade, reduce inflammation through blocking proinflammatory cytokines and mediators as well as NLRP3 inflammasome activity resulting attenuate apoptosis, and autophagy | Malvidin attenuated hepatocyte apoptosis and autophagy via an upregulating Nrf2 signalling pathway | [39] |
|
Genistein | D-galactosamine induced liver fibrosis/chronic liver damage in rats | Inhibit activation of reduced expression in α-SMA and deposition of collagen matrix and elevation in blood serum AST, ALT and leads to increased expression of hepatocellular Smad7. Which finally muffles the expression of smad/TGF-β1 signalling | Alterations in histopathology brought on by D-GlN are substantially prevented by genistein (5 mg/kg BW) | [64] |
|
Daidzein | LPS-induced hepatotoxicity | Inhibit inflammation and oxidative stress by reducing the level of AST, ALT, IL-6 IL-1β, and TNF and also increase the level of SOD by upregulating and downregulating Keap-1 | Daidzein was found effective to ameliorate oxidative stress and inflammation in LPS-induced hepatotoxicity | [65] |
Hepatocellular carcinoma | Reduce the expression of the cyclin D1/CDK4 axis and the cyclin A/CDK2 axis in the liver tissue via downregulation of Bcl-2, and suppressing the expression of Ki-67 | The daidzein and chicory combination was found to be effective to treat hepatocarcinogenesis | [66] |
|